NSF Peer Review

In his response to the petition we recently submitted requesting reforms in the National Science Foundation’s peer review process (“NSF Official Scoffs At Allegations, Asking: ‘What Secret Filing System?’ The Scientist, Sept. 18, 1989, page 13), Jim McCullough [director of NSF’s program evaluation staff] accuses us of various distortions and errors. However, he does not rebut any of the basic arguments we made, nor even the most fundamental point of our petition&#

Written byEric Glitzenstein
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In his response to the petition we recently submitted requesting reforms in the National Science Foundation’s peer review process (“NSF Official Scoffs At Allegations, Asking: ‘What Secret Filing System?’ The Scientist, Sept. 18, 1989, page 13), Jim McCullough [director of NSF’s program evaluation staff] accuses us of various distortions and errors. However, he does not rebut any of the basic arguments we made, nor even the most fundamental point of our petition—that NSF’s peer review system has not satisfactorily safeguarded the legal rights of grant applicants. Indeed, the fact that McCullough neglects to even mention, let alone address, the federal statutes on which our petition is principally based—the Privacy Act and Federal Advisory Committee Act—simply serves to strengthen our contention that the agency has not taken the steps necessary to fully comply with these laws.

The most glaring example of McCullough’s failure to come to grips with the substance of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo
Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery